Global GABA Receptor Agonist Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 133
Published Date: 10 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global GABA Receptor Agonist Drug market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the GABA Receptor Agonist Drug industry chain, the market status of Attention Deficit Hyperactivity Disorder (ADHD) (Bamaluzole, Phenibut), Psychiatric Disorders and Depression (Bamaluzole, Phenibut), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of GABA Receptor Agonist Drug.
Regionally, the report analyzes the GABA Receptor Agonist Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global GABA Receptor Agonist Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the GABA Receptor Agonist Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the GABA Receptor Agonist Drug industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Pcs), revenue generated, and market share of different by Type (e.g., Bamaluzole, Phenibut).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the GABA Receptor Agonist Drug market.
Regional Analysis: The report involves examining the GABA Receptor Agonist Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the GABA Receptor Agonist Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to GABA Receptor Agonist Drug:
Company Analysis: Report covers individual GABA Receptor Agonist Drug manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards GABA Receptor Agonist Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Attention Deficit Hyperactivity Disorder (ADHD), Psychiatric Disorders and Depression).
Technology Analysis: Report covers specific technologies relevant to GABA Receptor Agonist Drug. It assesses the current state, advancements, and potential future developments in GABA Receptor Agonist Drug areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the GABA Receptor Agonist Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
GABA Receptor Agonist Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Bamaluzole
Phenibut
Baclofen
Gaboxadol
Klonopin (clonazepam)
Tiagbine
Market segment by Application
Attention Deficit Hyperactivity Disorder (ADHD)
Psychiatric Disorders and Depression
Alzheimer
Epilepsy and Seizure
Anxiety and Sleep Disorders
Obesity and Alcoholism
Major players covered
Advicenne
AstraZeneca
Athena Drug Delivery Solutions
Biocodex
Elan Corporation
Eli Lilly and Company
H.LundBeck, Merck and Co
GlaxoSmithKline
NovaDel Pharma
Novartis
OVATION Pharmaceuticals
Osmotica Pharmaceutical
Pfizer
sanofi-aventis
VIVUS
XenoPort
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe GABA Receptor Agonist Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of GABA Receptor Agonist Drug, with price, sales, revenue and global market share of GABA Receptor Agonist Drug from 2019 to 2024.
Chapter 3, the GABA Receptor Agonist Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the GABA Receptor Agonist Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and GABA Receptor Agonist Drug market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of GABA Receptor Agonist Drug.
Chapter 14 and 15, to describe GABA Receptor Agonist Drug sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of GABA Receptor Agonist Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global GABA Receptor Agonist Drug Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Bamaluzole
1.3.3 Phenibut
1.3.4 Baclofen
1.3.5 Gaboxadol
1.3.6 Klonopin (clonazepam)
1.3.7 Tiagbine
1.4 Market Analysis by Application
1.4.1 Overview: Global GABA Receptor Agonist Drug Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Attention Deficit Hyperactivity Disorder (ADHD)
1.4.3 Psychiatric Disorders and Depression
1.4.4 Alzheimer
1.4.5 Epilepsy and Seizure
1.4.6 Anxiety and Sleep Disorders
1.4.7 Obesity and Alcoholism
1.5 Global GABA Receptor Agonist Drug Market Size & Forecast
1.5.1 Global GABA Receptor Agonist Drug Consumption Value (2019 & 2023 & 2030)
1.5.2 Global GABA Receptor Agonist Drug Sales Quantity (2019-2030)
1.5.3 Global GABA Receptor Agonist Drug Average Price (2019-2030)
2.1 Advicenne
2.1.1 Advicenne Details
2.1.2 Advicenne Major Business
2.1.3 Advicenne GABA Receptor Agonist Drug Product and Services
2.1.4 Advicenne GABA Receptor Agonist Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Advicenne Recent Developments/Updates
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca GABA Receptor Agonist Drug Product and Services
2.2.4 AstraZeneca GABA Receptor Agonist Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 AstraZeneca Recent Developments/Updates
2.3 Athena Drug Delivery Solutions
2.3.1 Athena Drug Delivery Solutions Details
2.3.2 Athena Drug Delivery Solutions Major Business
2.3.3 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Product and Services
2.3.4 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Athena Drug Delivery Solutions Recent Developments/Updates
2.4 Biocodex
2.4.1 Biocodex Details
2.4.2 Biocodex Major Business
2.4.3 Biocodex GABA Receptor Agonist Drug Product and Services
2.4.4 Biocodex GABA Receptor Agonist Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Biocodex Recent Developments/Updates
2.5 Elan Corporation
2.5.1 Elan Corporation Details
2.5.2 Elan Corporation Major Business
2.5.3 Elan Corporation GABA Receptor Agonist Drug Product and Services
2.5.4 Elan Corporation GABA Receptor Agonist Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Elan Corporation Recent Developments/Updates
2.6 Eli Lilly and Company
2.6.1 Eli Lilly and Company Details
2.6.2 Eli Lilly and Company Major Business
2.6.3 Eli Lilly and Company GABA Receptor Agonist Drug Product and Services
2.6.4 Eli Lilly and Company GABA Receptor Agonist Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Eli Lilly and Company Recent Developments/Updates
2.7 H.LundBeck, Merck and Co
2.7.1 H.LundBeck, Merck and Co Details
2.7.2 H.LundBeck, Merck and Co Major Business
2.7.3 H.LundBeck, Merck and Co GABA Receptor Agonist Drug Product and Services
2.7.4 H.LundBeck, Merck and Co GABA Receptor Agonist Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 H.LundBeck, Merck and Co Recent Developments/Updates
2.8 GlaxoSmithKline
2.8.1 GlaxoSmithKline Details
2.8.2 GlaxoSmithKline Major Business
2.8.3 GlaxoSmithKline GABA Receptor Agonist Drug Product and Services
2.8.4 GlaxoSmithKline GABA Receptor Agonist Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 GlaxoSmithKline Recent Developments/Updates
2.9 NovaDel Pharma
2.9.1 NovaDel Pharma Details
2.9.2 NovaDel Pharma Major Business
2.9.3 NovaDel Pharma GABA Receptor Agonist Drug Product and Services
2.9.4 NovaDel Pharma GABA Receptor Agonist Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 NovaDel Pharma Recent Developments/Updates
2.10 Novartis
2.10.1 Novartis Details
2.10.2 Novartis Major Business
2.10.3 Novartis GABA Receptor Agonist Drug Product and Services
2.10.4 Novartis GABA Receptor Agonist Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Novartis Recent Developments/Updates
2.11 OVATION Pharmaceuticals
2.11.1 OVATION Pharmaceuticals Details
2.11.2 OVATION Pharmaceuticals Major Business
2.11.3 OVATION Pharmaceuticals GABA Receptor Agonist Drug Product and Services
2.11.4 OVATION Pharmaceuticals GABA Receptor Agonist Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 OVATION Pharmaceuticals Recent Developments/Updates
2.12 Osmotica Pharmaceutical
2.12.1 Osmotica Pharmaceutical Details
2.12.2 Osmotica Pharmaceutical Major Business
2.12.3 Osmotica Pharmaceutical GABA Receptor Agonist Drug Product and Services
2.12.4 Osmotica Pharmaceutical GABA Receptor Agonist Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Osmotica Pharmaceutical Recent Developments/Updates
2.13 Pfizer
2.13.1 Pfizer Details
2.13.2 Pfizer Major Business
2.13.3 Pfizer GABA Receptor Agonist Drug Product and Services
2.13.4 Pfizer GABA Receptor Agonist Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Pfizer Recent Developments/Updates
2.14 sanofi-aventis
2.14.1 sanofi-aventis Details
2.14.2 sanofi-aventis Major Business
2.14.3 sanofi-aventis GABA Receptor Agonist Drug Product and Services
2.14.4 sanofi-aventis GABA Receptor Agonist Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 sanofi-aventis Recent Developments/Updates
2.15 VIVUS
2.15.1 VIVUS Details
2.15.2 VIVUS Major Business
2.15.3 VIVUS GABA Receptor Agonist Drug Product and Services
2.15.4 VIVUS GABA Receptor Agonist Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 VIVUS Recent Developments/Updates
2.16 XenoPort
2.16.1 XenoPort Details
2.16.2 XenoPort Major Business
2.16.3 XenoPort GABA Receptor Agonist Drug Product and Services
2.16.4 XenoPort GABA Receptor Agonist Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 XenoPort Recent Developments/Updates
3.1 Global GABA Receptor Agonist Drug Sales Quantity by Manufacturer (2019-2024)
3.2 Global GABA Receptor Agonist Drug Revenue by Manufacturer (2019-2024)
3.3 Global GABA Receptor Agonist Drug Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of GABA Receptor Agonist Drug by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 GABA Receptor Agonist Drug Manufacturer Market Share in 2023
3.4.2 Top 6 GABA Receptor Agonist Drug Manufacturer Market Share in 2023
3.5 GABA Receptor Agonist Drug Market: Overall Company Footprint Analysis
3.5.1 GABA Receptor Agonist Drug Market: Region Footprint
3.5.2 GABA Receptor Agonist Drug Market: Company Product Type Footprint
3.5.3 GABA Receptor Agonist Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global GABA Receptor Agonist Drug Market Size by Region
4.1.1 Global GABA Receptor Agonist Drug Sales Quantity by Region (2019-2030)
4.1.2 Global GABA Receptor Agonist Drug Consumption Value by Region (2019-2030)
4.1.3 Global GABA Receptor Agonist Drug Average Price by Region (2019-2030)
4.2 North America GABA Receptor Agonist Drug Consumption Value (2019-2030)
4.3 Europe GABA Receptor Agonist Drug Consumption Value (2019-2030)
4.4 Asia-Pacific GABA Receptor Agonist Drug Consumption Value (2019-2030)
4.5 South America GABA Receptor Agonist Drug Consumption Value (2019-2030)
4.6 Middle East and Africa GABA Receptor Agonist Drug Consumption Value (2019-2030)
5.1 Global GABA Receptor Agonist Drug Sales Quantity by Type (2019-2030)
5.2 Global GABA Receptor Agonist Drug Consumption Value by Type (2019-2030)
5.3 Global GABA Receptor Agonist Drug Average Price by Type (2019-2030)
6.1 Global GABA Receptor Agonist Drug Sales Quantity by Application (2019-2030)
6.2 Global GABA Receptor Agonist Drug Consumption Value by Application (2019-2030)
6.3 Global GABA Receptor Agonist Drug Average Price by Application (2019-2030)
7.1 North America GABA Receptor Agonist Drug Sales Quantity by Type (2019-2030)
7.2 North America GABA Receptor Agonist Drug Sales Quantity by Application (2019-2030)
7.3 North America GABA Receptor Agonist Drug Market Size by Country
7.3.1 North America GABA Receptor Agonist Drug Sales Quantity by Country (2019-2030)
7.3.2 North America GABA Receptor Agonist Drug Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe GABA Receptor Agonist Drug Sales Quantity by Type (2019-2030)
8.2 Europe GABA Receptor Agonist Drug Sales Quantity by Application (2019-2030)
8.3 Europe GABA Receptor Agonist Drug Market Size by Country
8.3.1 Europe GABA Receptor Agonist Drug Sales Quantity by Country (2019-2030)
8.3.2 Europe GABA Receptor Agonist Drug Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific GABA Receptor Agonist Drug Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific GABA Receptor Agonist Drug Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific GABA Receptor Agonist Drug Market Size by Region
9.3.1 Asia-Pacific GABA Receptor Agonist Drug Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific GABA Receptor Agonist Drug Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America GABA Receptor Agonist Drug Sales Quantity by Type (2019-2030)
10.2 South America GABA Receptor Agonist Drug Sales Quantity by Application (2019-2030)
10.3 South America GABA Receptor Agonist Drug Market Size by Country
10.3.1 South America GABA Receptor Agonist Drug Sales Quantity by Country (2019-2030)
10.3.2 South America GABA Receptor Agonist Drug Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa GABA Receptor Agonist Drug Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa GABA Receptor Agonist Drug Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa GABA Receptor Agonist Drug Market Size by Country
11.3.1 Middle East & Africa GABA Receptor Agonist Drug Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa GABA Receptor Agonist Drug Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 GABA Receptor Agonist Drug Market Drivers
12.2 GABA Receptor Agonist Drug Market Restraints
12.3 GABA Receptor Agonist Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of GABA Receptor Agonist Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of GABA Receptor Agonist Drug
13.3 GABA Receptor Agonist Drug Production Process
13.4 GABA Receptor Agonist Drug Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 GABA Receptor Agonist Drug Typical Distributors
14.3 GABA Receptor Agonist Drug Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global GABA Receptor Agonist Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global GABA Receptor Agonist Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Advicenne Basic Information, Manufacturing Base and Competitors
Table 4. Advicenne Major Business
Table 5. Advicenne GABA Receptor Agonist Drug Product and Services
Table 6. Advicenne GABA Receptor Agonist Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Advicenne Recent Developments/Updates
Table 8. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 9. AstraZeneca Major Business
Table 10. AstraZeneca GABA Receptor Agonist Drug Product and Services
Table 11. AstraZeneca GABA Receptor Agonist Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. AstraZeneca Recent Developments/Updates
Table 13. Athena Drug Delivery Solutions Basic Information, Manufacturing Base and Competitors
Table 14. Athena Drug Delivery Solutions Major Business
Table 15. Athena Drug Delivery Solutions GABA Receptor Agonist Drug Product and Services
Table 16. Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Athena Drug Delivery Solutions Recent Developments/Updates
Table 18. Biocodex Basic Information, Manufacturing Base and Competitors
Table 19. Biocodex Major Business
Table 20. Biocodex GABA Receptor Agonist Drug Product and Services
Table 21. Biocodex GABA Receptor Agonist Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Biocodex Recent Developments/Updates
Table 23. Elan Corporation Basic Information, Manufacturing Base and Competitors
Table 24. Elan Corporation Major Business
Table 25. Elan Corporation GABA Receptor Agonist Drug Product and Services
Table 26. Elan Corporation GABA Receptor Agonist Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Elan Corporation Recent Developments/Updates
Table 28. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 29. Eli Lilly and Company Major Business
Table 30. Eli Lilly and Company GABA Receptor Agonist Drug Product and Services
Table 31. Eli Lilly and Company GABA Receptor Agonist Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Eli Lilly and Company Recent Developments/Updates
Table 33. H.LundBeck, Merck and Co Basic Information, Manufacturing Base and Competitors
Table 34. H.LundBeck, Merck and Co Major Business
Table 35. H.LundBeck, Merck and Co GABA Receptor Agonist Drug Product and Services
Table 36. H.LundBeck, Merck and Co GABA Receptor Agonist Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. H.LundBeck, Merck and Co Recent Developments/Updates
Table 38. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 39. GlaxoSmithKline Major Business
Table 40. GlaxoSmithKline GABA Receptor Agonist Drug Product and Services
Table 41. GlaxoSmithKline GABA Receptor Agonist Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. GlaxoSmithKline Recent Developments/Updates
Table 43. NovaDel Pharma Basic Information, Manufacturing Base and Competitors
Table 44. NovaDel Pharma Major Business
Table 45. NovaDel Pharma GABA Receptor Agonist Drug Product and Services
Table 46. NovaDel Pharma GABA Receptor Agonist Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. NovaDel Pharma Recent Developments/Updates
Table 48. Novartis Basic Information, Manufacturing Base and Competitors
Table 49. Novartis Major Business
Table 50. Novartis GABA Receptor Agonist Drug Product and Services
Table 51. Novartis GABA Receptor Agonist Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Novartis Recent Developments/Updates
Table 53. OVATION Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 54. OVATION Pharmaceuticals Major Business
Table 55. OVATION Pharmaceuticals GABA Receptor Agonist Drug Product and Services
Table 56. OVATION Pharmaceuticals GABA Receptor Agonist Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. OVATION Pharmaceuticals Recent Developments/Updates
Table 58. Osmotica Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 59. Osmotica Pharmaceutical Major Business
Table 60. Osmotica Pharmaceutical GABA Receptor Agonist Drug Product and Services
Table 61. Osmotica Pharmaceutical GABA Receptor Agonist Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Osmotica Pharmaceutical Recent Developments/Updates
Table 63. Pfizer Basic Information, Manufacturing Base and Competitors
Table 64. Pfizer Major Business
Table 65. Pfizer GABA Receptor Agonist Drug Product and Services
Table 66. Pfizer GABA Receptor Agonist Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Pfizer Recent Developments/Updates
Table 68. sanofi-aventis Basic Information, Manufacturing Base and Competitors
Table 69. sanofi-aventis Major Business
Table 70. sanofi-aventis GABA Receptor Agonist Drug Product and Services
Table 71. sanofi-aventis GABA Receptor Agonist Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. sanofi-aventis Recent Developments/Updates
Table 73. VIVUS Basic Information, Manufacturing Base and Competitors
Table 74. VIVUS Major Business
Table 75. VIVUS GABA Receptor Agonist Drug Product and Services
Table 76. VIVUS GABA Receptor Agonist Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. VIVUS Recent Developments/Updates
Table 78. XenoPort Basic Information, Manufacturing Base and Competitors
Table 79. XenoPort Major Business
Table 80. XenoPort GABA Receptor Agonist Drug Product and Services
Table 81. XenoPort GABA Receptor Agonist Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. XenoPort Recent Developments/Updates
Table 83. Global GABA Receptor Agonist Drug Sales Quantity by Manufacturer (2019-2024) & (K Pcs)
Table 84. Global GABA Receptor Agonist Drug Revenue by Manufacturer (2019-2024) & (USD Million)
Table 85. Global GABA Receptor Agonist Drug Average Price by Manufacturer (2019-2024) & (USD/Pcs)
Table 86. Market Position of Manufacturers in GABA Receptor Agonist Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 87. Head Office and GABA Receptor Agonist Drug Production Site of Key Manufacturer
Table 88. GABA Receptor Agonist Drug Market: Company Product Type Footprint
Table 89. GABA Receptor Agonist Drug Market: Company Product Application Footprint
Table 90. GABA Receptor Agonist Drug New Market Entrants and Barriers to Market Entry
Table 91. GABA Receptor Agonist Drug Mergers, Acquisition, Agreements, and Collaborations
Table 92. Global GABA Receptor Agonist Drug Sales Quantity by Region (2019-2024) & (K Pcs)
Table 93. Global GABA Receptor Agonist Drug Sales Quantity by Region (2025-2030) & (K Pcs)
Table 94. Global GABA Receptor Agonist Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 95. Global GABA Receptor Agonist Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 96. Global GABA Receptor Agonist Drug Average Price by Region (2019-2024) & (USD/Pcs)
Table 97. Global GABA Receptor Agonist Drug Average Price by Region (2025-2030) & (USD/Pcs)
Table 98. Global GABA Receptor Agonist Drug Sales Quantity by Type (2019-2024) & (K Pcs)
Table 99. Global GABA Receptor Agonist Drug Sales Quantity by Type (2025-2030) & (K Pcs)
Table 100. Global GABA Receptor Agonist Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 101. Global GABA Receptor Agonist Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 102. Global GABA Receptor Agonist Drug Average Price by Type (2019-2024) & (USD/Pcs)
Table 103. Global GABA Receptor Agonist Drug Average Price by Type (2025-2030) & (USD/Pcs)
Table 104. Global GABA Receptor Agonist Drug Sales Quantity by Application (2019-2024) & (K Pcs)
Table 105. Global GABA Receptor Agonist Drug Sales Quantity by Application (2025-2030) & (K Pcs)
Table 106. Global GABA Receptor Agonist Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 107. Global GABA Receptor Agonist Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 108. Global GABA Receptor Agonist Drug Average Price by Application (2019-2024) & (USD/Pcs)
Table 109. Global GABA Receptor Agonist Drug Average Price by Application (2025-2030) & (USD/Pcs)
Table 110. North America GABA Receptor Agonist Drug Sales Quantity by Type (2019-2024) & (K Pcs)
Table 111. North America GABA Receptor Agonist Drug Sales Quantity by Type (2025-2030) & (K Pcs)
Table 112. North America GABA Receptor Agonist Drug Sales Quantity by Application (2019-2024) & (K Pcs)
Table 113. North America GABA Receptor Agonist Drug Sales Quantity by Application (2025-2030) & (K Pcs)
Table 114. North America GABA Receptor Agonist Drug Sales Quantity by Country (2019-2024) & (K Pcs)
Table 115. North America GABA Receptor Agonist Drug Sales Quantity by Country (2025-2030) & (K Pcs)
Table 116. North America GABA Receptor Agonist Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 117. North America GABA Receptor Agonist Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 118. Europe GABA Receptor Agonist Drug Sales Quantity by Type (2019-2024) & (K Pcs)
Table 119. Europe GABA Receptor Agonist Drug Sales Quantity by Type (2025-2030) & (K Pcs)
Table 120. Europe GABA Receptor Agonist Drug Sales Quantity by Application (2019-2024) & (K Pcs)
Table 121. Europe GABA Receptor Agonist Drug Sales Quantity by Application (2025-2030) & (K Pcs)
Table 122. Europe GABA Receptor Agonist Drug Sales Quantity by Country (2019-2024) & (K Pcs)
Table 123. Europe GABA Receptor Agonist Drug Sales Quantity by Country (2025-2030) & (K Pcs)
Table 124. Europe GABA Receptor Agonist Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 125. Europe GABA Receptor Agonist Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 126. Asia-Pacific GABA Receptor Agonist Drug Sales Quantity by Type (2019-2024) & (K Pcs)
Table 127. Asia-Pacific GABA Receptor Agonist Drug Sales Quantity by Type (2025-2030) & (K Pcs)
Table 128. Asia-Pacific GABA Receptor Agonist Drug Sales Quantity by Application (2019-2024) & (K Pcs)
Table 129. Asia-Pacific GABA Receptor Agonist Drug Sales Quantity by Application (2025-2030) & (K Pcs)
Table 130. Asia-Pacific GABA Receptor Agonist Drug Sales Quantity by Region (2019-2024) & (K Pcs)
Table 131. Asia-Pacific GABA Receptor Agonist Drug Sales Quantity by Region (2025-2030) & (K Pcs)
Table 132. Asia-Pacific GABA Receptor Agonist Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 133. Asia-Pacific GABA Receptor Agonist Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 134. South America GABA Receptor Agonist Drug Sales Quantity by Type (2019-2024) & (K Pcs)
Table 135. South America GABA Receptor Agonist Drug Sales Quantity by Type (2025-2030) & (K Pcs)
Table 136. South America GABA Receptor Agonist Drug Sales Quantity by Application (2019-2024) & (K Pcs)
Table 137. South America GABA Receptor Agonist Drug Sales Quantity by Application (2025-2030) & (K Pcs)
Table 138. South America GABA Receptor Agonist Drug Sales Quantity by Country (2019-2024) & (K Pcs)
Table 139. South America GABA Receptor Agonist Drug Sales Quantity by Country (2025-2030) & (K Pcs)
Table 140. South America GABA Receptor Agonist Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 141. South America GABA Receptor Agonist Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 142. Middle East & Africa GABA Receptor Agonist Drug Sales Quantity by Type (2019-2024) & (K Pcs)
Table 143. Middle East & Africa GABA Receptor Agonist Drug Sales Quantity by Type (2025-2030) & (K Pcs)
Table 144. Middle East & Africa GABA Receptor Agonist Drug Sales Quantity by Application (2019-2024) & (K Pcs)
Table 145. Middle East & Africa GABA Receptor Agonist Drug Sales Quantity by Application (2025-2030) & (K Pcs)
Table 146. Middle East & Africa GABA Receptor Agonist Drug Sales Quantity by Region (2019-2024) & (K Pcs)
Table 147. Middle East & Africa GABA Receptor Agonist Drug Sales Quantity by Region (2025-2030) & (K Pcs)
Table 148. Middle East & Africa GABA Receptor Agonist Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 149. Middle East & Africa GABA Receptor Agonist Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 150. GABA Receptor Agonist Drug Raw Material
Table 151. Key Manufacturers of GABA Receptor Agonist Drug Raw Materials
Table 152. GABA Receptor Agonist Drug Typical Distributors
Table 153. GABA Receptor Agonist Drug Typical Customers
List of Figures
Figure 1. GABA Receptor Agonist Drug Picture
Figure 2. Global GABA Receptor Agonist Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global GABA Receptor Agonist Drug Consumption Value Market Share by Type in 2023
Figure 4. Bamaluzole Examples
Figure 5. Phenibut Examples
Figure 6. Baclofen Examples
Figure 7. Gaboxadol Examples
Figure 8. Klonopin (clonazepam) Examples
Figure 9. Tiagbine Examples
Figure 10. Global GABA Receptor Agonist Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 11. Global GABA Receptor Agonist Drug Consumption Value Market Share by Application in 2023
Figure 12. Attention Deficit Hyperactivity Disorder (ADHD) Examples
Figure 13. Psychiatric Disorders and Depression Examples
Figure 14. Alzheimer Examples
Figure 15. Epilepsy and Seizure Examples
Figure 16. Anxiety and Sleep Disorders Examples
Figure 17. Obesity and Alcoholism Examples
Figure 18. Global GABA Receptor Agonist Drug Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 19. Global GABA Receptor Agonist Drug Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 20. Global GABA Receptor Agonist Drug Sales Quantity (2019-2030) & (K Pcs)
Figure 21. Global GABA Receptor Agonist Drug Average Price (2019-2030) & (USD/Pcs)
Figure 22. Global GABA Receptor Agonist Drug Sales Quantity Market Share by Manufacturer in 2023
Figure 23. Global GABA Receptor Agonist Drug Consumption Value Market Share by Manufacturer in 2023
Figure 24. Producer Shipments of GABA Receptor Agonist Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 25. Top 3 GABA Receptor Agonist Drug Manufacturer (Consumption Value) Market Share in 2023
Figure 26. Top 6 GABA Receptor Agonist Drug Manufacturer (Consumption Value) Market Share in 2023
Figure 27. Global GABA Receptor Agonist Drug Sales Quantity Market Share by Region (2019-2030)
Figure 28. Global GABA Receptor Agonist Drug Consumption Value Market Share by Region (2019-2030)
Figure 29. North America GABA Receptor Agonist Drug Consumption Value (2019-2030) & (USD Million)
Figure 30. Europe GABA Receptor Agonist Drug Consumption Value (2019-2030) & (USD Million)
Figure 31. Asia-Pacific GABA Receptor Agonist Drug Consumption Value (2019-2030) & (USD Million)
Figure 32. South America GABA Receptor Agonist Drug Consumption Value (2019-2030) & (USD Million)
Figure 33. Middle East & Africa GABA Receptor Agonist Drug Consumption Value (2019-2030) & (USD Million)
Figure 34. Global GABA Receptor Agonist Drug Sales Quantity Market Share by Type (2019-2030)
Figure 35. Global GABA Receptor Agonist Drug Consumption Value Market Share by Type (2019-2030)
Figure 36. Global GABA Receptor Agonist Drug Average Price by Type (2019-2030) & (USD/Pcs)
Figure 37. Global GABA Receptor Agonist Drug Sales Quantity Market Share by Application (2019-2030)
Figure 38. Global GABA Receptor Agonist Drug Consumption Value Market Share by Application (2019-2030)
Figure 39. Global GABA Receptor Agonist Drug Average Price by Application (2019-2030) & (USD/Pcs)
Figure 40. North America GABA Receptor Agonist Drug Sales Quantity Market Share by Type (2019-2030)
Figure 41. North America GABA Receptor Agonist Drug Sales Quantity Market Share by Application (2019-2030)
Figure 42. North America GABA Receptor Agonist Drug Sales Quantity Market Share by Country (2019-2030)
Figure 43. North America GABA Receptor Agonist Drug Consumption Value Market Share by Country (2019-2030)
Figure 44. United States GABA Receptor Agonist Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. Canada GABA Receptor Agonist Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Mexico GABA Receptor Agonist Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Europe GABA Receptor Agonist Drug Sales Quantity Market Share by Type (2019-2030)
Figure 48. Europe GABA Receptor Agonist Drug Sales Quantity Market Share by Application (2019-2030)
Figure 49. Europe GABA Receptor Agonist Drug Sales Quantity Market Share by Country (2019-2030)
Figure 50. Europe GABA Receptor Agonist Drug Consumption Value Market Share by Country (2019-2030)
Figure 51. Germany GABA Receptor Agonist Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. France GABA Receptor Agonist Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. United Kingdom GABA Receptor Agonist Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Russia GABA Receptor Agonist Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Italy GABA Receptor Agonist Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Asia-Pacific GABA Receptor Agonist Drug Sales Quantity Market Share by Type (2019-2030)
Figure 57. Asia-Pacific GABA Receptor Agonist Drug Sales Quantity Market Share by Application (2019-2030)
Figure 58. Asia-Pacific GABA Receptor Agonist Drug Sales Quantity Market Share by Region (2019-2030)
Figure 59. Asia-Pacific GABA Receptor Agonist Drug Consumption Value Market Share by Region (2019-2030)
Figure 60. China GABA Receptor Agonist Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Japan GABA Receptor Agonist Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. Korea GABA Receptor Agonist Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. India GABA Receptor Agonist Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Southeast Asia GABA Receptor Agonist Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Australia GABA Receptor Agonist Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. South America GABA Receptor Agonist Drug Sales Quantity Market Share by Type (2019-2030)
Figure 67. South America GABA Receptor Agonist Drug Sales Quantity Market Share by Application (2019-2030)
Figure 68. South America GABA Receptor Agonist Drug Sales Quantity Market Share by Country (2019-2030)
Figure 69. South America GABA Receptor Agonist Drug Consumption Value Market Share by Country (2019-2030)
Figure 70. Brazil GABA Receptor Agonist Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Argentina GABA Receptor Agonist Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Middle East & Africa GABA Receptor Agonist Drug Sales Quantity Market Share by Type (2019-2030)
Figure 73. Middle East & Africa GABA Receptor Agonist Drug Sales Quantity Market Share by Application (2019-2030)
Figure 74. Middle East & Africa GABA Receptor Agonist Drug Sales Quantity Market Share by Region (2019-2030)
Figure 75. Middle East & Africa GABA Receptor Agonist Drug Consumption Value Market Share by Region (2019-2030)
Figure 76. Turkey GABA Receptor Agonist Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. Egypt GABA Receptor Agonist Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 78. Saudi Arabia GABA Receptor Agonist Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 79. South Africa GABA Receptor Agonist Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 80. GABA Receptor Agonist Drug Market Drivers
Figure 81. GABA Receptor Agonist Drug Market Restraints
Figure 82. GABA Receptor Agonist Drug Market Trends
Figure 83. Porters Five Forces Analysis
Figure 84. Manufacturing Cost Structure Analysis of GABA Receptor Agonist Drug in 2023
Figure 85. Manufacturing Process Analysis of GABA Receptor Agonist Drug
Figure 86. GABA Receptor Agonist Drug Industrial Chain
Figure 87. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 88. Direct Channel Pros & Cons
Figure 89. Indirect Channel Pros & Cons
Figure 90. Methodology
Figure 91. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Advicenne AstraZeneca Athena Drug Delivery Solutions Biocodex Elan Corporation Eli Lilly and Company H.LundBeck, Merck and Co GlaxoSmithKline NovaDel Pharma Novartis OVATION Pharmaceuticals Osmotica Pharmaceutical Pfizer sanofi-aventis VIVUS XenoPort
Related Reports
11 Feb 2021
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
